Search Results

There are 13981 results for: content related to: Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

  1. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  2. Rituximab, an Anti-CD20 Monoclonal Antibody

    Immunotherapy in Transplantation: Principles and Practice

    Bruce Kaplan, Gilbert J. Burckart, Fadi G. Lakkis, Pages: 362–377, 2012

    Published Online : 19 APR 2012, DOI: 10.1002/9781444355628.ch24

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x

  5. You have free access to this content
    Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action

    American Journal of Transplantation

    Volume 6, Issue 5p1, May 2006, Pages: 859–866, M. D. Pescovitz

    Version of Record online : 20 MAR 2006, DOI: 10.1111/j.1600-6143.2006.01288.x

  6. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  7. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  8. You have free access to this content
    Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12498

  9. Experience with low-dose rituximab in off-label indications at two tertiary hospitals

    Internal Medicine Journal

    Volume 43, Issue 8, August 2013, Pages: 871–882, J. Chay, P. Donovan, L. Cummins, P. Kubler and P. Pillans

    Version of Record online : 6 AUG 2013, DOI: 10.1111/imj.12207

  10. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  11. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Version of Record online : 14 FEB 2014, DOI: 10.1111/hiv.12136

  12. You have free access to this content
    Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1215–1226, Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P. Garg, Paul Brunetta, Gerald Appel and LUNAR Investigator Group

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.34359

  13. Off-label use of rituximab in a tertiary Queensland hospital

    Internal Medicine Journal

    Volume 40, Issue 6, June 2010, Pages: 443–452, S. J. Butterly, P. Pillans, B. Horn, R. Miles and J. Sturtevant

    Version of Record online : 21 MAY 2009, DOI: 10.1111/j.1445-5994.2009.01988.x

  14. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  15. You have free access to this content
    Repeated courses of rituximab in chronic ITP: Three different regimens

    American Journal of Hematology

    Volume 84, Issue 10, October 2009, Pages: 661–665, Aisha Hasan, Marc Michel, Vivek Patel, Roberto Stasi, Susanna Cunningham-Rundles, John P. Leonard and James Bussel

    Version of Record online : 25 JUL 2009, DOI: 10.1002/ajh.21512

  16. You have free access to this content
    Model-based design of rituximab dosage optimization in follicular non-Hodgkin's lymphoma

    British Journal of Clinical Pharmacology

    Volume 73, Issue 4, April 2012, Pages: 597–605, David Ternant, Guillaume Cartron, Emilie Hénin, Michel Tod, Pascal Girard and Gilles Paintaud

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1365-2125.2011.04125.x

  17. You have full text access to this Open Access content
    Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy

    Cancer Science

    Volume 100, Issue 1, January 2009, Pages: 54–61, Akiko Miyagi Maeshima, Hirokazu Taniguchi, Junko Nomoto, Dai Maruyama, Sung-Won Kim, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai and Yoshihiro Matsuno

    Version of Record online : 25 NOV 2008, DOI: 10.1111/j.1349-7006.2008.01005.x

  18. Low-dose rituximab is effective in pemphigus

    British Journal of Dermatology

    Volume 166, Issue 2, February 2012, Pages: 405–412, B. Horváth, J. Huizinga, H.H. Pas, A.B. Mulder and M.F. Jonkman

    Version of Record online : 9 JAN 2012, DOI: 10.1111/j.1365-2133.2011.10663.x

  19. Low-dose rituximab in adult patients with primary immune thrombocytopenia

    European Journal of Haematology

    Volume 85, Issue 4, October 2010, Pages: 329–334, Francesco Zaja, Nicola Vianelli, Stefano Volpetti, Marta Lisa Battista, Marzia Defina, Salvatore Palmieri, Monica Bocchia, Marta Medeot, Stefano De Luca, Felicetto Ferrara, Miriam Isola, Michele Baccarani and Renato Fanin

    Version of Record online : 10 JUN 2010, DOI: 10.1111/j.1600-0609.2010.01486.x

  20. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial

    International Journal of Dermatology

    Volume 52, Issue 7, July 2013, Pages: 862–867, Balighi Kamran, Daneshpazhooh Maryam, Khezri Somayeh, Mahdavi-nia Mostafa, Hajiseyed-javadi Mahsa and Chams-Davatchi Cheyda

    Version of Record online : 23 JUN 2013, DOI: 10.1111/j.1365-4632.2012.5847.x

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 52, Issue 10, 1292, Version of Record online: 23 SEP 2013